Dr. Varga is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000
Summary
- I received my MD from New York University. Following Medicine residency at Rhode Island Hospital, trained in Rheumatology at Boston University, and then completed a basic research post-doc at the University of Pennsylvania
I moved to the Midwest in 1995, and joined the faculty at Northwestern University in 2004. I founded the Scleroderma Program and run a basic/translational research lab focusing on fibrosis and precision medicine
Education & Training
- University of Pennsylvania Health SystemFellowship, Rheumatology, 1985 - 1987
- Boston University Medical CenterFellowship, Rheumatology, 1983 - 1985
- Brown UniversityResidency, Internal Medicine, 1980 - 1983
- New York University School of MedicineClass of 1980
Certifications & Licensure
- MI State Medical License 2020 - 2026
- IL State Medical License 1995 - 2020
- PA State Medical License 1985 - 1996
Awards, Honors, & Recognition
- Member Association of American Physicians
- Member AOA
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Join now to see all
Publications & Presentations
PubMed
- 72 citationsInterferon‐γ reverses the stimulation of collagen but not fibronectin gene expression by transforming growth factor‐β in normal human fibroblastsJohn Varga, Anne Olsen, J. Herhal, G. Constantine, Joel Rosenbloom
European Journal of Clinical Investigation. 1990-10-01 - 52 citationsNegative modulation of alpha1 (I) procollagen gene expression in human skin fibroblasts : transcriptional inhibition by interferon-gammaWeihua Yuan, Tatyana Yufit, Liye Li, Yasuji Mori, Shu Jen Chen
Journal of Cellular Physiology. 1999-04-01 - 33 citationsSelective inhibition of collagen gene expression in fibroblasts by an interferon-gamma transgene.H. A. Jaffe, Zhancheng Gao, Yasuji Mori, Liye Li, John Varga
Experimental Lung Research. 1999-01-01
Journal Articles
- Emerging Targets of Disease-Modifying Therapy for Systemic SclerosisElizabeth R Volkmann, John Varga, Nature
- Adipocyte-Specific Repression of PPAR-Gamma by NCoR Contributes to Scleroderma Skin FibrosisWarren Tourtellotte, Benjamin Korman, John Varga, BioMed Central
Other
- Overview of the clinical manifestations of systemic sclerosis (scleroderma) in adultsVarga J
http://www.uptodate.com/contents/overview-of-the-clinical-manifestations-of-systemic-sclerosis-scler
UpToDate, Wolters Kluwer Health - 2012-11-19 - Diagnosis and differential diagnosis of systemic sclerosis (scleroderma) in adultsVarga J
http://www.uptodate.com/contents/diagnosis-and-differential-diagnosis-of-systemic-sclerosis-sclerode
UpToDate, Wolters Kluwer Health - 2012-11-19 - Risk factors for and possible causes of systemic sclerosis (scleroderma)Varga J
http://www.uptodate.com/contents/risk-factors-for-and-possible-causes-of-systemic-sclerosis-sclerode
UpToDate, Wolters Kluwer Health - 2012-04-17 - Join now to see all
Press Mentions
- Antibody Targeting CD38 Enzyme Shows Positive Impact in Treating Systemic SclerosisSeptember 6th, 2024
- Could Getting Rid of Old Cells Turn Back the Clock on Aging?January 2nd, 2023
- How the Western Diet and Gut Bacteria Can Lead to Scarring, Vessel Damage in SclerodermaAugust 23rd, 2022
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: